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The IL-17 family contributes to host defense against many intracellular pathogens by
mechanisms that are not fully understood. CD8+ T lymphocytes are key elements
against intracellular microbes, and their survival and ability to mount cytotoxic responses
are orchestrated by several cytokines. Here, we demonstrated that IL-17RA-signaling
cytokines sustain pathogen-specific CD8+ T cell immunity. The absence of IL-17RA
and IL-17A/F during Trypanosoma cruzi infection resulted in increased tissue parasitism
and reduced frequency of parasite-specific CD8+ T cells. Impaired IL-17RA-signaling
in vivo increased apoptosis of parasite-specific CD8+ T cells, while in vitro recombinant
IL-17 down-regulated the pro-apoptotic protein BAD and promoted the survival of
activated CD8+ T cells. Phenotypic, functional, and transcriptomic profiling showed that
T. cruzi-specific CD8+ T cells derived from IL-17RA-deficient mice presented features
of cell dysfunction. PD-L1 blockade partially restored the magnitude of CD8+ T cell
responses and parasite control in these mice. Adoptive transfer experiments established
that IL-17RA-signaling is intrinsically required for the proper maintenance of functional
effector CD8+ T cells. Altogether, our results identify IL-17RA and IL-17A as critical
factors for sustaining CD8+ T cell immunity to T. cruzi.
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INTRODUCTION
IL-17A and IL-17F were initially associated with the pathogenesis of autoinflammatory and
autoimmune disorders (1). Nonetheless, the primary function of these cytokines is likely host
protection against microbes. Indeed, mice deficient in IL-17A and/or IL-17F are highly susceptible
to infection with a wide array of fungi and extracellular bacteria, as well as viruses and parasites
(2, 3). We previously demonstrated that the IL-17 family of cytokines plays a critical role in host
survival by regulating exuberant inflammation and immunopathology during infection with the
protozoan Trypanosoma cruzi (4, 5). Additional data from our laboratory suggests that IL-17 plays
additional protective roles against T. cruzi by modulating adaptive immunity.
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The IL-17 family is comprised of 6 members, IL-17A to IL-
17F, which have different cellular sources and expression patterns
but often show overlapping activities. The cytokines signal
through a receptor complex composed of at least two identical
or different subunits of the IL-17R family (IL-17RA to IL-17RE).
IL-17RA is the common signaling subunit used by at least four
ligands: IL-17A, IL-17C, IL-17E, and IL-17F. IL-17 members
regulate inflammation by recruiting and activating neutrophils,
NK cells, and other cells of the innate immune system and
by inducing several pro-inflammatory mediators (i.e., cytokines,
chemokines, microbial peptides, and metalloproteinases). In
addition, these cytokines play important roles during adaptive
immune responses, including the modulation of germinal center
reactions, as well as the regulation of Th1 and CD8+ cellular
responses (6–9).
Infection with T. cruzi is known to cause Chagas disease,
the third most frequent parasitic disease worldwide that is
endemic in Latin America and is increasing globally due
to migratory flows. Disease progression, from asymptomatic
to severe cardiac and digestive forms, is linked to parasite
heterogeneity and variable host immune responses. CD8+ T cell
mediated immunity is essential for parasite control throughout
the various stages of infection, although it is not sufficient for
complete parasite elimination (10, 11). CD8+ T cell deficient
mice are extremely susceptible to infection (12, 13), and strategies
that improve specific CD8+ T cell responses result in increased
host protection (11, 14, 15). This finding, coupled with the
fact that parasite persistence correlates with disease severity in
human and experimental models of T. cruzi infection (16, 17),
have prompted efforts to better understand the mechanisms that
promote anti-parasitic CD8+ T cell immunity.
The general features of protective CD8+ T cell responses
(as defined with model viral and bacterial infections) consist of
the generation and expansion of short-lived, highly functional
effector populations with antimicrobial activities. After the
pathogen has been cleared, most of the effector cells die
and the few remaining cells differentiate into memory T
cells, contributing to long-lived immunological protection (18).
Persistently activated CD8+ T cells can become dysfunctional
during certain chronic infections, which results in a hierarchical
loss of effector functions and proliferation potential, as well
as sustained expression of multiple inhibitory receptors. Severe
exhaustion leads to pathogen-specific cells that are prone to
deletion and have reduced ability to produce cytokines and
degranulate. These exhausted CD8+ T cells fail to provide
optimal protection and contribute to poor pathogen control (19).
In addition to antigen-specific and co-stimulatory signals, which
are the driving forces behind CD8+ T cell responses, various
cytokines (i.e., IL-21, IL-2, IL-12) are required to provide the
“third-signal” essential for protective CD8+ T cell immunity
(20, 21).
Herein, we demonstrate that IL-17RA signaling is required
for the maintenance of robust, specific CD8+ T cell responses
that contribute to host resistance to T. cruzi. We show
that absence of IL-17RA signaling during T. cruzi infection
alters the transcriptional program of effector CD8+ T cells,
and consequently affects their survival, effector function, and
exhaustion. Our findings are relevant for gaining a better
understanding of the role of the IL-17 family in the orchestration
of protective immunity against infections.
MATERIALS AND METHODS
Mice
Mice used for experiments were sex- and age-matched (6 to
10 weeks-old). C57BL/6 mice were obtained from School of
Veterinary, La Plata National University (La Plata, Argentina).
IL-17RA KO mice were provided by Amgen Inc. (Master
Agreement N◦ 200716544-002). IL-17A/IL-17F double KO mice
(22) were kindly provided by Dr Immo Prinz. CD45.1 C57BL/6
mice (B6.SJL-Ptprca Pepcb/Boy) and CD8α KO mice (B6.129S2-
Cd8atm1Mak/J) were obtained from The Jackson Laboratories
(USA). CD45.1 × CD45.2 F1 WT mice bred in our animal
facility. All animals were housed in the Facultad de Ciencias
Químicas, Universidad Nacional de Córdoba.
Parasites and Experimental Infection
Bloodstream trypomastigotes of the Tulahuén strain of T. cruzi
were obtained from BALB/c mice infected 10 days earlier. For
experimental infection mice were inoculated intraperitoneally
with 0.2ml PBS containing 5× 103 trypomastigotes (usual dose)
or doses of 500 and 5× 104 trypomastigotes when indicated. For
infection of transferred CD8α knockout mice, parasite dose was
1,000 trypomastigotes.
Quantification of Parasite DNA in Tissues
Genomic DNA was purified from 50 µg of tissue (spleen,
liver, and heart) using TRIzol Reagent (Life Technologies)
following manufacturer’s instructions. Satellite DNA from T.
cruzi (GenBank AY520036) was quantified by real time PCR
using specific Custom Taqman Gene Expression Assay (Applied
Biosystem) using the primer and probe sequences described by
Piron et al. (23). A sample was considered positive for the T.
cruzi target when CT < 45. Abundance of satellite DNA from
T. cruzi was normalized to GAPDH abundance (Taqman Rodent
GAPDH Control Reagent, Applied Biosystem) and expressed as
arbitrary units.
Cells and Culture
CD8+ T cells were isolated from the spleen by magnetic negative
selection or cell sorting from pools of at least 3-5 mice. For
magnetic cell purification the EasySep
TM
Mouse CD8+ T Cell
Isolation Kit (Stemcell Technologies) were used according to the
manufacturer’s protocol. For cell sorting, spleen cell suspensions
were surface stained and CD3+CD8+ T cells were sorted with a
FACSAria II (BD Biosciences). During in vitro studies, CD8+ T
cells (2 × 105) purified by magnetic selection were stimulated in
96-well plates coated with anti-CD3/anti-CD28Abs (eBioscience,
2 and 1µg/ml respectively) and incubated during 24 h in the
presence of 100 ng/ml of recombinant IL-17A, IL-17F, IL-17C,
and IL-17E (ImmunoTools, GmbH) and/or 50 ng/mL of IL-21
and TNF (ImmunoTools, GmbH). For camptothecin challenge,
the drug was added in a concentration of 5µM from the
beginning of the culture.
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Antibodies and Flow Cytometry
Cell suspensions were washed in PBS and incubated with
LIVE/DEADFixable Cell Dead Stain (eBioscience) during 15min
at RT. Next, cells were washed and incubated with fluorochrome
labeled-Abs for 20min at 4◦C (see below for details). To
detect T. cruzi specific CD8+ T cells, H-2K(b) T. cruzi trans-
sialidase amino acids 567-574 ANYKFTLV (TSKB20) APC-
Labeled Tetramer (NIH Tetramer Core Facility) were incubated
20min at 4◦C before further surface staining with additional
Abs. After further surface staining, cells were washed and
acquired in a FACSCanto II (BD Biosciences). Blood was directly
incubated with the indicated antibodies and erythrocytes were
lysed with a 0.87% NH4Cl buffer previously to acquisition.
For Ki-67 intranuclear staining, cells were first stained on
surface, washed and then fixed, permeabilized and stained
with Foxp3/Transcription Factor Staining Buffers (eBioscience)
following eBioscience One-step protocol: intracellular (nuclear)
proteins.
Flow cytometry and/or cell sorting was performed with a
combination of the following Abs (BD Biosciences, Biolegend,
eBioscience, Life Technologies, Santa Cruz Biotechnology or Cell
Signaling): FITC/AF488-labeled anti-mouse: CD8 (53-6.7), anti-
CD25 (7D4), CD69 (H1.2F3), CD44 (IM7), Bcl-2 (10C4), IgG
(polyclonal goat), and anti-rat IgG (polyclonal goat); PE-labeled
anti-mouse: Fas (Jo2), CTLA-4 (UC10-4B9), PD-1 (RMP1-30),
Ki-67 (SolA15), IL-17RA (PAJ17R), CD120b (TR75-89), Bim
(rabbit. C34C5), rabbit IgG control isotype (DA1E); PECy7-
labeled anti-mouse: CD8 (53-6.7), PD-1 (RMP1-30), FAS (Jo2)
and anti-CD25 (P61.5); PerCPCy5.5-labeled anti-mouse: CD3
(145-2C11), CD45.2 (104); PerCP-eFluor 710 labeled anti-mouse:
TIGIT (GIGD7); APC-Cy7/AF780-labeled anti-mouse: CD45.1
(A20) and CD62L (MEL-14); Biotin-labeled anti-mouse: BTLA
(8F4) and PE-labeled Streptavidin; unlabeled anti-mouse: Bcl-xL
(rabbit, 54H7), Bcl-2-associated death promoter (BAD) (rabbit,
C-20), Bax (rabbit, P-19).
Quantification of IL-21
The concentration of IL-21 in the plasma of in plasma of infected
WT and IL-17RA KO mice was assessed by ELISA using paired
specific Abs (eBiosciences) according to standard protocols.
Evaluation of Proliferation and Apoptosis
T. cruzi-infected WT and IL-17RA KO mice were given BrdU
(1 mg/ml, Sigma-Aldrich)/1% sucrose in the drinking water
(carefully protected from light) ad libitum. After 5 days, mice
were sacrificed and spleen mononuclear cells were collected
and stained with surface antibodies. Incorporated BrdU was
detected with a BrdU Flow kit according to the manufacturer’s
specifications (BD Biosciences).
Apoptosis was determined by Annexin V and 7AAD staining
according to the manufacturer’s specifications (BD Biosciences).
Mitochondrial depolarization (ψ) was measured by FACS using
50 nM TMRE (Invitrogen) as described (24). When indicated,
7AAD or LIVE/DEAD Fixable Aqua dead cell stain was
used in combination to identify live, early apoptotic and late
apoptotic/necrotic cells.
Determination of CD8+ T Cell Effector
Function in vitro
Spleen cell suspensions were cultured during 5 h with medium,
5µg/ml TSKB20 (ANYKFTLV) peptide (Genscript Inc.), 50 nM
PMA plus 0.5µg/ml ionomycin (Sigma-Aldrich) in the presence
of Monensin and Brefeldin A (eBioscience). When indicated
a PE-labeled anti-CD107a mAb (eBioscience, eBio1D4B)
was included during the culture period. After culture, the
cells were surface stained, fixed and permeabilized with BD
Cytofix/Cytoperm and Perm/Wash (BD Biosciences) according
manufacturer’s instruction. Cells were incubated with FITC-
labeled antibodies to IFNγ (eBioscience, XMG1.2) or Perforin-1
(eBoscience, eBioOMAK-D), PerCP/PerCP-eFluor 710 labeled
antibody to TNF (Biolegend, MP6-XT22) or Granzyme A
(eBiosciences, GzA-3G8.5) and/or APC/AF647-labeled antibody
to TNF (Biolegend, MP6-XT22) or Granzyme B (Biolegend,
GB11). Stained cells were acquired on FACSCanto II (BD
Biosciences).
Adoptive Cell Transfer
Competitive adoptive transfer experiments were performed by
i.v. injection of recipient CD45.1+/CD45.2+ WT mice (F1
hybrid obtained by crossing CD45.1+ and CD45.2+ WT mice)
or CD8α knockout mice with a mixture 1:1 of CD8+ T cells
purified from spleen of CD45.1+ WT mice and CD45.2+ IL-
17RA KO mice. Total 5 × 106 cells and 15 × 106 cells were
injected in WT and CD8α knockout recipients, respectively.
Recipient mice were immediately infected and frequency of the
injected CD45.1+ WT and CD45.2+ IL-17RA KO cells within
the total T cell population were determined in blood, spleen and
liver at different days pi.
To address the relevance of CD8+ T cell-intrinsic IL-17RA
signaling forT. cruzi infection progression, CD8α knockout hosts
were injected i.v. with the same number (7 × 106) of CD8+
T cells purified from spleen of WT or IL-17RA KO mice and
immediately infected. Transfer of equal number of CD8+ T
cells in both mouse groups was evaluated 1 day after injection
by analyzing the frequency of CD8+ T cells in blood. The
progression of the infection was followed by the quantification
of parasitemia and survival. Infected non-transferred CD8α
knockout mice were used as control.
Treatment With Neutralizing Anti- IL-17A
and PD-L1 Abs
To block the PD-1/PD-L1 pathway, infected WT and IL-17RA
KO mice were injected i.p. with 200 µg rat anti-mouse PD-L1
antibody (10F.9G2, BioXcell) or total rat IgG isotype control
(Jackson Research) every 3 days from 15 dpi until sacrifice at day
21 dpi. Infection matched WT mice were assayed in parallel as
controls.
For the in vivo neutralization of IL-17A, infected WT mice
were injected i.p. with 200 µg rat anti-mouse IL-17 antibody
(17F3, BioXcell) or rat total IgG1 isotype control (MOPC-21,
BioXcell) every 3 days from day 13 dpi until sacrifice at 21 dpi.
Infection-matched IL-17RA KO mice were assayed in parallel as
controls.
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FIGURE 1 | Absence of IL-17RA signaling results in increased tissue parasitism and a reduced magnitude of parasite-specific CD8+ T cell responses. (A-C) Relative
amount of T. cruzi satellite DNA in spleen (A), liver (B) and heart (C) of infected WT and IL-17RA KO (KO) mice determined at the indicated dpi. Murine GAPDH was
used for normalization. Data are presented as mean ± SD, N = 5 mice. P values calculated with two-tailed T test. (D) Representative plots of CD8 and TSKB20/Kb
staining in spleen, liver and blood of WT and KO mice at 22 dpi (WT-I and KO-I, respectively). A representative plot of the staining of splenocytes from non-infected WT
mice (WT-N) is shown for comparison. (E) Percentage and cell numbers of TSKB20/Kb+ CD8+ T cells and (F) cell numbers of total CD8+ T cells determined in
spleen of WT and IL-17RA KO mice at different dpi. Data shown as mean ± SD, N = 5−8 mice. P values calculated using two-way ANOVA followed by Bonferroni‘s
post-test. (G) Experimental layout of IL-17 neutralization in infected WT mice injected with control isotype or anti-IL-17 Abs (WT-cAb and WT-aIL-17, respectively). (H)
Representative plots of CD8 and TSKB20/Kb staining in spleen and liver infected control and treated WT mice. (I) Percentage of total and TSKB20/Kb+ CD8+ T cells
infected control and treated WT mice. Results from infection-matched WT (WT-I) and KO mice (KO-I) are shown for comparison. Data are representative of five (A–F),
and two (G–I) independent experiments.
Real-Time Quantitative PCR and DNA
Microarray
RNA from total spleen tissue was purified using TRIzol Reagent
(Life Technologies) followingmanufacturer’s instructions. Oligo-
dT and a MMLV reverse transcriptase kit (Invitrogen) were
used for cDNA synthesis. IL-17RA, IL-17RC, and IL-17RD
transcripts were quantified by real-time quantitative PCR
on an ABI PRISM 7700 Sequence Detector (Perkin-Elmer
Applied Biosystems) with Applied Biosystems predesigned
TaqMan Gene Expression Assays and reagents according to
the manufacturer’s instructions. The following probes were
used: Mm00434214_m1 for IL-17RA, Mm00506606_m1 for IL-
17RC and Mm00460340_m1 for IL-17RD. For each sample,
the mRNA abundance was normalized to the amount of 18S
rRNA (Mm03928990_g1) and is expressed as arbitrary units
(AU).
For gene-expression analysis, CD8+ T cells were purified by
FACS from the spleen of non-infected and 22-day infected WT
and IL-17RA KO mice and lysed with TRIzol reagent. Total
RNA was extracted with the RNAeasy Mini Kit (Qiagen). RNA
quality was verified in an Agilent Bioanalyzer and measured with
a Nanodrop 1000 (Thermo Scientific). cDNA was hybridized on
Affymetrix Mouse Gene 2.1 ST arrays as described elsewhere.
Analysis of Microarray Data
The microarray data from this publication have been deposited
to the GEO database (https://www.ncbi.nlm.nih.gov/geo/) and
assigned the identifier: GSE104886. Gene expression data was
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FIGURE 2 | IL-17RA signaling during T. cruzi infection promotes survival of CD8+ T cells. (A) Representative dot plots of CD8 and TSKB20/Kb staining and
representative histograms of BrDU in cell suspensions from the spleen of WT and KO mice at 0 dpi (WT-N) and 20 dpi (WT-I and KO-I) and within the indicated total
and TSKB20/Kb+ CD8+ T cell gates. Numbers in the histograms indicate the frequency of BrDU+ cells from the corresponding colored group. Histograms are
representative of one out of five mice. Bars in the statistical analysis represent data as mean ± SD, N = 5 mice. P values were calculated with two-tailed T test. (B)
Representative histograms of TMRE staining in total (left) and TSKB20/Kb+ (right) CD8+ T cells from the spleen of WT and IL17RA KO mice at 10 dpi (top) and 20 dpi
(bottom). Numbers indicate the frequency of TMRE- (apoptotic) cells in total and TSKB20/Kb+ CD8+ T cells from the corresponding colored group. Gray tinted
histogram show staining in CD8+ T cells from non-infected WT mice (WT-N). Histograms are representative of one out of five mice. Bars in the statistical analysis
represent data as mean ± SD, N = 5 mice. P values were calculated with two-tailed T test. (C, D) Representative histograms of TMRE (C) and BAD (D) stainings in
cultures of purified CD8+ T cells activated with coated anti-CD3 and anti-CD28 in the presence of the indicated cytokines. Statistical analysis in (C) shows the
frequency of TMRE- (apoptotic) cells in each biological replicate (N = 4 mice) and the mean ± SD. P values calculated with paired two-tailed T test (ns, not
significant). Statistical analysis in (D) represent protein expression as the geometric mean of fluorescence intensity in each replicate (N = 4 mice). Lines link paired
samples. P values calculated with paired two-tailed T test. Data in (A-D) are representative of three and two independent experiments, respectively.
normalized using RMA algorithm on custom Brainarray CDF
(v.22.0.0 ENTREZG). Plots of differential expressed genes in
spleen CD8T cells at day 0 post infection and day 22 post
infection in WT and IL-17RA KO samples were defined
using fold change [|log2FC| >log2(1.2)]. Bioinformatic analyses
were performed with R software environment. Heatmaps were
produced using Heatmapper (http://www.heatmapper.ca) and
show gene expression of CD8+ T cells from WT and IL-17RA
KO normalized by the average of the gene expression in non-
infected counterparts, except specified. Gene Set Enrichment
Analyses (GSEA) between the different spleen CD8T cell samples
were done using specific gene sets from the Molecular Signatures
DB (MSigDB). Genes induced by the infection in WT and
IL-17RA KO mice but showing significantly higher expression
in IL-17RA KO mice were uploaded to Ingenuity Pahtway
Analysis (Ingenuity R© Systems, www.ingenuity.com) for the
analysis of “Disease and bio-function,” “Canonical pathway,” and
“Up-stream regulators.” It was considered significantly activated
(or inhibited) with an overlap p ≤ 0.05 and an IPA activation
Z-score as defined under each specific analysis category on the
IPA website.
Statistics
Statistical significance of comparisons of mean values was
assessed as indicated by a two-tailed Student’s t test, two
way ANOVA followed by Bonferroni’s posttest and Gehan-
Breslow-Wilcoxon Test using GraphPad software. P < 0.05 was
considered statistically significant.
RESULTS
IL-17RA and IL-17A/IL-17F Deficiencies
Compromise Parasite Control and Reduce
the Magnitude of the Specific CD8+ T Cell
Response During T. cruzi Infection
We previously showed that IL-17RA-signaling and IL-17-
secreting B cells are required for host survival during T. cruzi
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infection by, at least in part, regulating innate immunity and
inflammation (4, 5). In addition, histological data from these
initial studies suggested that infected IL-17RA knockout (KO)
mice exhibited increased parasite levels in tissues, but similar
levels of parasitemia, compared with those of their infected
wildtype (WT) counterparts (4). To confirm this and to study
possible additional protective mechanisms mediated by IL-17,
we evaluated tissue parasitism in infected WT and IL-17RA KO
mice. As determined by the amounts of parasite DNA quantified
in the spleen, we observed that T. cruzi infected IL-17RA KO
mice controlled tissue parasitism similar to WT mice during
the first 2 weeks of infection (Figure 1A). However, IL-17RA
KO mice failed to reduce the parasite burden at later stages of
infection, as attested by the increased parasite load in the spleen at
22 and 130 days post-infection (dpi) (Figure 1A). Furthermore,
increased parasite levels were also detected in other organs, such
as liver and heart (Figures 1B,C).
Given that the aforementioned result suggested a deteriorated
adaptive immune response, we focused on studying the role
of IL-17RA in the development of parasite-specific CD8+ T
cells. To this end, we examined the generation of CD8+
T cells specific for the immunodominant epitope TSKB20
(T. cruzi trans-sialidase amino acids 569-576 –ANYKFTLV–)
(25) in infected IL-17RA KO and WT mice. We determined
that the frequency of TSKB20-specific CD8+ T cells was
reduced in the spleen, liver, and blood of infected IL-17RA
KO mice at 20 dpi (Figure 1D). Kinetics studies showed that
the frequency and absolute numbers of TSKB20-specific CD8+
T cells in the spleen of infected IL-17RA KO mice was
similar to that of infected WT control mice up to 14 dpi,
but these values dropped dramatically soon after (Figure 1E).
Remarkably, total CD8+ T cell numbers at 20 dpi were
also reduced in the spleen of infected IL-17RA KO mice
(Figure 1F). In agreement with the notion that IL-17A and IL-
17F are the major IL-17RA-signaling cytokines that modulate
immune responses, IL-17A/IL-17F double knockout (DKO)mice
also showed increased tissue parasitism in spleen and liver
(Supplementary Figure 1A) and reduced frequency of parasite-
specific CD8+ T cells in comparison to WT control mice
(Supplementary Figure 1B).
Considering the kinetics of the TSKB20-specific CD8+ T cell
immunity observed in infected IL-17RA KO mice (Figure 1E),
along with our results showing that IL-17 production peaked
around 14 dpi (4, 5), we speculated that IL-17RA signaling
plays a role during the expansion and maintenance of parasite-
specific CD8+ T cells after priming. To test this, we performed
neutralization experiments in which infected WT mice were
injected with anti-IL-17A antibodies (Abs) from 13 to 19 dpi
(Figure 1G). A blockade of IL-17 signaling, specifically during
the expansion/maintenance phase, resulted in a significant
decrease in the frequency of TSKB20-specific T cells (Figure 1H).
Indeed, mice treated with anti-IL-17 once the CD8+ T cell
response was already established (from 13 to 19 dpi), showed
a frequency of parasite-specific T cells comparable to that
observed in infected IL-17RA KO mice that were devoid
of IL-17 signaling throughout the entire infection period
(Figure 1I).
Absence of IL-17RA Signaling During
T. cruzi Infection Reduces the Survival of
Total and Specific CD8+ T Cells
Considering the conventional kinetics of T cell responses
(18), it was conceivable that the abortive CD8+ T cell
response observed in infected IL-17RA KO mice could be
a consequence of reduced cell expansion and/or increased
contraction. To address the role of IL-17RA in CD8+ T
cell proliferation, we assessed the in vivo incorporation of
BrdU between 15 and 20 dpi, as these time points directly
preceded the dramatic decrease in the numbers of specific
CD8+ T cells in infected IL-17RA KO mice. The results
depicted in Figure 2A demonstrate that the absence of IL-
17RA does not compromise proliferation of CD8+ T cells
during T. cruzi infection. Complementary studies of ex vivo
detection of the Ki-67 antigen led to similar conclusions
(Supplementary Figure 2A). We then tested a possible role
of IL-17RA signaling in supporting CD8+ T cell survival.
In comparison to their infected WT counterparts, total and
TSKB20-specific CD8+ T cells from infected IL-17RA KO mice
showed significantly higher frequencies of apoptotic cells as early
as 10 dpi and also at later time points (20 dpi) (Figure 2B).
Similar results were obtained by analyzing Annexin V+/7AAD-
cells (Supplementary Figure 2B). In the same direction, total
and parasite-specific CD8+ T cells from infected WT mice
treated with anti-IL-17A Abs (Figure 1H) showed higher
percentage of apoptotic cells than their counterparts from WT
mice, and exhibited levels of apoptosis similar to that of infected
IL-17RA KOmice (Supplementary Figure 2C).
Given the results described above, we evaluated whether
cytokines that signal through IL-17RA were able to directly
increase survival of activated CD8+ T cells. CD8+ T cells
purified from the spleen of non-infected WTmice were activated
for 24 h with plastic-coated anti-CD3 and anti-CD28 Abs in
the presence of recombinant cytokines. The addition of IL-
17A, but not IL-17F, IL-17C, or IL-17E, lead to a modest but
significant reduction in the percentage of apoptotic activated
CD8+ T cells (Figure 2C). Of note, the direct anti-apoptotic
effect of IL-17 in CD8+ T cells was comparable to that of IL-
21, a well-recognized survival factor for this population (26).
We also determined that CD8+ T cells purified from the
spleen of IL-17RA KO mice and activated in vitro were more
susceptible to cell death (apoptosis and necrosis) induced by
camptothecin (CPT) challenge than CD8+ T cells fromWTmice
(Supplementary Figure 2D). As expected based on the lack of
IL-17RA expression, IL-17 was not able to reduce activation-
or CPT-induced cell death in CD8+ T cells from IL-17RA KO
mice. However, IL-17 also failed to reduce the cell death triggered
by CPT in CD8+ T cells from WT mice. The differential effect
of IL-17 in protecting CD8+ T cells from TCR- but not CPT-
induced cell death may result from differences in the apoptotic
signaling pathways triggered by these two treatments (27, 28).
In an attempt to elucidate the mechanisms underlying the pro-
survival effects of IL-17A against activation-induced apoptosis,
we evaluated the expression of pro- and anti-apoptotic members
of the Bcl-2 superfamily that are critically involved in the
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regulation of T cell death (29). We determined that IL-17A
significantly downregulated the expression of Bad (Figure 2D).
Little to no changes were observed in other members such as Bcl-
xL, Bcl-2, Bim, and Bax (Supplementary Figure 2E). Altogether,
these results indicate that IL-17A may promote CD8+ T cell
survival by down-regulating pro-apoptotic factors in the Bcl-2
family.
Absence of IL-17RA Perturbs the
Transcriptional Program of CD8+ T Cells
Activated During T. cruzi Infection
To gain further insights into the role of IL-17RA signaling
during T. cruzi infection, we determined the gene expression
profiles of purified CD8+ T cells using Affymetrix microarrays.
Using gene expression data normalized to the corresponding
non-infected samples, we compared the transcriptional changes
induced by infection in CD8+ T cells from IL-17RA KO mice
vs. WT mice in a fold change/fold change plot. We identified
4287 genes that showed significant expression differences (greater
than 1.2 fold; p < 0.05) and grouped these genes into different
sets according to the differential expression patterns (Figure 3A).
Remarkably, 1,647 genes (pink, orange and red sets) were
expressed at higher level in CD8+ T cells from IL-17RA KO
infected mice in comparison to WT counterparts, whereas 2,640
genes (light green, green and dark sets) were expressed at lower
levels. To further evaluate the biological characteristics of the
transcriptional landscape of CD8+ T cells from infected IL-17RA
KO vs. WT mice, we performed gene-enrichment set analysis
(GSEA) for the genes that were differentially expressed. After
conducting a broad analysis using gene ontology, as well as
immunological and curated databases, we decided to focus on
specific gene sets (Molecular Signatures DB-MSigDB) related to
CD8+ T cell function and differentiation, such as GSEA26495
and GSEA41867. This supervised analysis showed that IL-17RA
KO CD8+ T cells were significantly enriched in six gene sets in
which themost enriched CD8+T cell gene sets in the significance
order (size of FWER P values) were PD1hi vs. PD1low (p < 0.001)
and Naïve vs. PD1low (p < 0.001) (Figure 3B). These results
denoted that CD8+ T cells derived from IL-17RA KO mice
infected with T. cruzi showed a phenotype with characteristics
of dysfunctional and, surprisingly, naïve cells.
We then analyzed the expression patterns of genes within
the categories relevant for CD8+ T cell biology and IL-17RA
signaling. Direct comparison of the gene expression profiles
of CD8+ T cells from infected WT and IL-17RA KO mice
after normalization of the date to gene expression in cell from
non-infected mice revealed that absence of IL-17 expression
resulted in important differencesin the transcriptional profile of
CD8+ T cells (Figure 3C). Indeed, genes encoding activation
and effector cell markers, such as the KLRG family molecules
CD11c and CD69, showed a completely opposite pattern of
expression in CD8+ T cells from infected IL-17RA KO vs. WT
mice. Furthermore, CD8+ T cells from infected IL-17RA KO
mice showed clearly increased expression of genes encoding
inhibitory and death receptors, including Ctla4, Havcr2 (Tim3),
Pdcd1 (PD1), Tigit, and Fas. We also analyzed how the absence
of IL-17RA signaling affected the expression of genes encoding
transcription factors (TFs) that regulate CD8+ T cell fate. Of
note, there was a group of TF-encoding genes whose expression
was significantly higher in CD8+ T cells from infected IL-
17RA KO mice than in those of their WT counterparts. This
group included genes such as Foxo1, Irf4, and Foxo3 that are
critical for the generation of effector CD8+ T cells (30, 31).
Also, we determined that CD8+ T cells from infected WT
and IL-17RA mice showed differences in the expression of
many genes encoding effector molecules, cytokine receptors,
homing and migration molecules, and apoptosis mediators, thus
further supporting the fact that absence of IL-17RA influences
CD8+ T cell fate. Finally, analysis of the gene expression
of molecules associated to IL-17RA signaling (6) evidenced
significant differences between CD8+ T cells from infected WT
and IL-17RA KO mice. Thus, CD8+ T cells from WT mice
showed increased amounts of transcripts encoding MMP-13,
CCL-20, and IL-6 among others while CD8+ T cells from IL-
17RA KO mice showed higher amounts of transcripts encoding
TNF, IKBKb, CXCL-2, S100a8, MMP-8, and others (Figure 3D).
To broadly analyze the significance of the transcriptional
differences between CD8+ T cells from infected IL-17RA KO
mice and their WT counterparts, we performed an Ingenuity
Pathway Analysis (IPA) on genes marked in red in Figure 3A.
The genes were up-regulated in infected CD8+ T cells from
both groups of mice, but were expressed at significantly higher
levels in CD8+ T cells from IL-17RA KO mice. The top
20 “Diseases and Bio-functions,” “Canonical pathways,” and
“Upstream regulators” that were most significantly altered in
CD8+ T cells from IL-17RA KO mice infected with T. cruzi are
shown in Figures 3E–G. Interestingly, “Cell death,” “Apoptosis of
Lymphocytes” bio-functions (Figure 3E) and the “p53 Signaling”
(Figure 3F) canonical pathway emerged as significantly up-
regulated. These results support the notion that the lack of IL-
17RA signaling during T. cruzi infection significantly affected
the survival and senescence status of CD8+ T cells, as well as
various biological features. Finally, to elucidate which molecule/s
were involved in the observed differences in gene expression,
we performed an “upstream regulator analysis” (Figure 3G).
Many modulators of the inflammatory responses, including the
cytokines IL-2 and IL-6 and the NF-κB regulators CHUK and
IKBKG, were significantly up-regulated in CD8+ T cells from
infected IL-17RA KO mice. Conversely, the genes for MKL-2
and MKL-1, which interact with transcriptional regulator serum
response factor, were down-regulated. Notably, IRF4, and to a
lesser extent other TFs such as BATF, STAT1, and AHR, emerged
as potential upstream regulators of the transcriptional program
induced by T. cruzi infection in CD8+ T cells from IL-17RA KO
mice.
Absence of IL-17RA Signaling During
T. cruzi Infection Results in CD8+ T Cell
Exhaustion
Given the results obtained from the microarray analysis, we
performed a phenotypic characterization of the CD8+ T
cells from the different experimental mouse groups. Analysis
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FIGURE 3 | Substantial differences in the gene-expression profile of CD8+ T cells from T. cruzi-infected IL-17RA KO and WT mice. (A–F) Microarray analysis of
purified CD8+ T cells from infected WT (WT-I) and IL-17RA KO (KO-I) mice (22 dpi) and non-infected controls (WT-N and KO-N). N = 3 mice per group. (A) Dot plot
displaying the number of genes that show a significant ≥1.2-fold difference in fold change expression of WT-I and KO-I relative to non-infected counterparts. Colors
indicate sets of genes with different expression patterns. (B) Top two enrichment plots in KO-I (p < 0.001) determined by supervised analysis of all infection induced
genes in WT-I and KO-I using GSEA26495 and GSEA41867 (MSigDB C5BP) signature gene sets. (C) Heat maps of expression of selected genes according to
categories relevant to CD8+ T cell biology. The gene expression values of each sample were normalized by division to the average values of the corresponding
samples from non-infected counterparts. (D) Heat map of expression of genes encoding molecules associated to IL-17RA signaling. Gene expression values
represent non-normalized data from 3 mice. (E–G) IPA of genes induced by the infection but showing significantly higher expression in IL-17RA KO mice (red genes in
A). Top 20 “Diseases and Bio-functions” (E), “Canonical pathways” (F), and “Up-stream regulators” (G) that were most significantly altered (P < 0.05 with Fischer’s
exact test) in KO mice are shown. The activation Z-score was calculated to predict activation (red), inhibition (blue), categories where no predictions can be made and
unknown results (with Z-score close to 0). Categories significantly activated or inhibited according to Z-score are marked with a star.
of CD62L vs. CD44 expression showed that upon T. cruzi
infection, more than 80% of the total CD8+ T cells from the
spleen of infected WT and IL-17RA KO mice acquired an
activated/effector phenotype characterized by CD62LlowCD44hi
expression (Figure 4A). Within the TSKB20-specific population,
the effector cells constituted more than 95% of the total number
of cells. These results highlighted that CD8+ T cell activation
triggered by T. cruzi infection is not compromised in the absence
of IL-17RA. Indeed, total and parasite-specific CD8+ T cells
from the infected IL-17RA KO mice had significantly elevated
expression of prototypical activation markers such as CD69 and
CD25 in comparison to that of CD8+ T cells from WT mice
(Figure 4B), which corroborated the results from our microarray
analysis.
We next determined the expression of inhibitory and death
receptors in CD8+ T cells from WT and IL-17RA KO mice
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FIGURE 4 | CD8+ T cells from T. cruzi infected IL-17RA KO mice show phenotypic and functional features compatible with exhausted cells. Representative flow
cytometry data that show the phenotype of total and TSKB20/Kb+ CD8+ T cells from the spleen of infected WT (WT-I) and IL-17RA (KO-I) mice (22 dpi). Stainings of
non-infected WT (WT-N) and KO (KO-N) mice are showed in plots or gray tinted histograms for comparison. (A) Plots of CD62L vs. CD44 expression. Gates indicate
the frequency of naïve, memory and effector subsets. (B–D) Representative histograms and statistical analysis of the geometric mean of expression or percentage of
cells that express activation markers (B), inhibitory receptors (C), and death receptors (D) in total and TSKB20/Kb+ CD8+ T cells from the spleen of infected WT (WT-I)
and IL-17RA (KO-I) mice (22 dpi). Data in statistical analysis (B–D) are presented as mean ± SD, N = 4−6 mice. (E) Percentage of CD8+ T cells from the spleen of
non-infected (N) and 22-day infected (I) WT and KO mice expressing Granzyme A (GzmA), Perforin (Prf) or Granzime B (GzmB) after 5 h of PMA/Ionomycin stimulation.
Data shown as mean ± SD, N = 2−5 mice. (F) Percentage of CD8+ T cells from the spleen of 22-day infected WT and KO mice that exhibit different combinations of
effector functions including CD107a mobilization and/or IFNγ and/or TNF production upon 5 h of the indicated stimulation. Data shown as mean ± SD, N = 5 mice.
Data were background subtracted. All P values were calculated using two-tailed T test. Data are representative of two-three independent experiments.
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infected with T. cruzi. The total and TSKB20-specific CD8+
T cells from infected WT mice had an increased frequency of
PD-1+ and CTLA-4+ cells, slightly higher TIGIT expression,
and reduced frequency of BTLA+ cells compared to that of
non-infected mice (Figure 4C). Notably, total and TSKB20-
specific CD8+ T cells from infected IL-17RA KO mice
showed significantly increased frequency of PD-1+, CTLA-
4+ and BTLA+ cells as well as higher expression of TIGIT.
Furthermore, these cells presented an apoptotic phenotype
characterized by the expression of high levels of CD95/Fas
and CD120b/TNF-R2 (Figure 4D). Total and TSKB20-specific
CD8+ T cells from infected IL-17A/IL-17F DKO mice showed
a profile of expression of inhibitory (PD-1) and death receptors
(Fas/CD95) that was comparable to that of total and TSKB20-
specific CD8+ T cells from infected IL-17RA KO mice
(Supplementary Figures 1C,D).
Further phenotypic characterization included effector
molecules involved in cytotoxicity such as Granzyme A (GzmA),
Granzyme B (GzmB), and Perforin-1 (Prf). As GzmB and
Prf were barely detectable ex vivo (data not shown), the
expression of the three cytotoxic molecules was determined
in splenocytes from non-infected and infected WT and IL-
17RA KO mice after 5 h of stimulation with PMA/ionomycin
(Supplementary Figure 4A). In agreement with the microarray
data, we determined that CD8+ T cells from infected IL-17RA
KO mice had significantly reduced expression of GzmA in
comparison to their counterparts from infected WT mice,
whereas the expression levels of GzmB and Prf were similar
between both groups (Figure 4E).
To address whether the phenotypic features of CD8+ T
cells elicited in absence of IL-17RA correlated with altered
functionality, we compared the effector function of CD8+
T cells from infected WT and IL-17RA KO mice. To this
end, we analyzed the mobilization of CD107a and secretion
of effector cytokines upon specific and polyclonal activation
in vitro. Stimulation of splenocytes from infected IL-17RA
KO mice with the TSKB20 peptide resulted in a significant
reduction of the frequency of CD8+ T cells with polyfunctional
characteristics (i.e., surface CD107a expression and IFNγ and/or
TNF production) in comparison to WT control mice (Figure 4F,
left panel and Supplementary Figure 3). Although a poor
response was anticipated due to the low frequency of TSKB20-
specific CD8+ T cells in infected IL-17RA KOmice, the antigen-
specific effector response of CD8+ T cells was not significantly
different from background, suggesting the presence of both
quantitative and qualitative defects. Polyclonal stimulation with
PMA/ionomycin increased the percentage of CD8+ T cells
from infected IL-17RA KO mice that had a polyfunctional
response, although the magnitude of this effector response was
significantly lower than that of WT mice (Figure 4F, right panel
and Supplementary Figure 3).
To determine if the higher parasite burden in infected IL-
17RA KO mice may underlie the upregulation of inhibitory
receptors in CD8+ T cells from these mice, we evaluated
the phenotype of CD8+ T cells from WT mice infected with
increasing parasite doses. Interestingly, increasing the load of
T. cruzi did not diminish the frequency of parasite-specific CD8+
T cells, nor did it promote the upregulation of the inhibitory and
death receptors evaluated (Supplementary Figures 4B–D).
Checkpoint Blockade Partially Restores
Parasite-Specific CD8+ T Cell Immunity
and Enhances Parasite Control in Infected
IL-17RA KO Mice
CD8+ T cell exhaustion has been associated with poor microbial
control during infection with various pathogens, as well as with
tumor progression in cancer. In these settings, a checkpoint
blockade has been shown to efficiently restore the magnitude and
functionality of effector T cells and minimize damage from the
insult (32). Furthermore, a PD-L1 blockade has been effective
in preventing T cell apoptosis in murine and human sepsis
models (33, 34). Our results highlight that the absence of IL-
17RA signaling during T. cruzi infection leads to poor CD8+
T cell effector function and parasite persistence. This prompted
us to evaluate whether a checkpoint blockade could restore a
resistance phenotype to infected IL-17RA KO mice. As PD-
1 is highly expressed on parasite-specific CD8+ T cells from
infected IL-17RA KO mice, we targeted this checkpoint receptor
by injecting blocking anti-PD-L1 Abs at 15 and 18 dpi, before
the contraction of a parasite-specific CD8+ T cell response
(Figure 5A). We determined that PD-L1 blockade in infected IL-
17RAKO significantly augmented themagnitude of the TSKB20-
specific CD8+ T cell response by 21 dpi, particularly in the
spleen and liver (Figure 5B). A similar response to treatment
was observed in infected WT mice. Notably, the enhanced T.
cruzi-specific CD8+ T cell immunity was correlated with a
marked reduction in the levels of tissue parasitism (Figure 5C).
In addition, inhibition of PD-L1 also lead to a milder infection, as
highlighted by the significantly reduced levels of several damage
biomarkers, such as the transaminase aspartate aminotransferase
(AST), creatine kinase total (CK), and myocardial band (CK-
MB) (Figure 5D). The rescue effects of the PD-L1 checkpoint
blockade during T. cruzi infection, namely parasite persistence
and tissue damage, were more impressive in IL-17RA KO mice
than inWTmice, as they showed extremely high susceptibility to
T. cruzi infection in the absence of treatment.
Intrinsic IL-17RA Signaling Modulates the
Maintenance and Phenotype of CD8+ T
Cells Activated During T. cruzi Infection
To understand if IL-17RA plays a direct role in the modulation
of CD8+ T cell responses to T. cruzi, we first quantified the
serum concentration of IL-21, a cytokine known to modulate
CD8+ T cell immunity (35). Of note, we determined that in
comparison to infected WT mice, infected IL-17RA KO mice
displayed higher expression of IL-21 (Figure 6A). This result
highlights that increased expression of IL-21 is not sufficient to
compensate for the lack of IL-17RA signaling via restoring CD8+
T cell responses during T. cruzi infection.
We next evaluated the possibility of a direct effect of IL-17RA
signaling in the modulation of CD8+ T cell responses, given
that IL-17RA is upregulated in response to cytokines that boost
CD8+ T cell responses such as IL-21 (26, 36). The IL-17RA
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FIGURE 5 | Checkpoint blockade reinvigorates parasite-specific CD8+ T cell immunity and enhances parasite control in infected IL-17RA KO mice. (A) Layout of the
checkpoint blockade experiment. (B) Representative plots and statistical analysis of CD8 and TSKB20/Kb staining in spleen and liver of the indicated experimental
groups. Numbers within plots indicate the frequency of total CD8+ cells (up) and TSKB20-specific CD8+ T cells (down) at 21 dpi. Bar graphs represent data as mean
± SD, N = 7 mice. (C) Relative amount of T. cruzi satellite DNA in the spleens of the indicated experimental groups at 21 dpi. Murine GAPDH was used for
normalization. Data are presented as mean ± SD relative to WT-cAb group, N = 7 mice. (D) Enzymatic activity (UI/L) of alanine transaminase (ALT), aspartate
transaminase (AST), creatinine kinase-MB and creatinine phosphokinase (CPK) on plasma of the indicated experimental groups at 21 dpi. N = 7 mice. All P values
were calculated with two-tailed T test. Data are representative of two independent experiments.
subunit interacts with IL-17RC to form the functional receptor
for both IL-17A and IL-17F [reviewed in Gaffen (6)]. Recently,
also IL-17RD was shown to bind to IL-17RA to differentially
regulate IL-17A-inducing signaling pathways (37, 38). Therefore,
we evaluated the mRNA levels of IL-17RA, IL-17RC, and IL-
17RD by quantitative PCR. In agreement with published data,
mRNA encoding IL-17RA were detected in splenic CD8+ T
cells (Figure 6B). Transcripts encoding Il17rc and Il17rd were
also detected in these cells, but at remarkably lower levels in
comparison to Il17ra. Studies by flow cytometry confirmed the
expression of IL-17RA on CD8+ T cells. Notably, IL-17RA
expression varied depending on the CD8+ T cell subset, and
was higher in memory cells defined as CD44hiCD62Lhi than
in the effector (CD44hiCD62Llo) and naïve (CD44loCD62Lhi)
subsets (Figure 6C). T. cruzi infection upregulated IL-17RA
expression in CD8+T cells, to levels and kinetics specific for each
subset (Figures 6C,D). We observed that IL-17RA expression
is substantially upregulated in bulk memory CD8+ T cells
during T. cruzi infection, but is only transiently increased in
bulk effector CD8+ T cells at early time points (Figure 6D). As
expected given their effector nature, TSKB20-specific CD8+ T
cells expressed IL-17RA at a level that was comparable to bulk
effector cells.
To directly address the impact of intrinsic IL-17RA signaling
in the development of CD8+ T cell responses during T. cruzi
infection, we performed a series of adoptive transfer experiments.
First, we transferred an equal number of congenically marked
IL-17RA-deficient (CD45.2+) and WT (CD45.1+) CD8+ T
cells into WT (CD45.1+/CD45.2+) recipient mice. Recipient
mice were infected, and the presence of injected cells in the
total and TSKB20-specific CD8+ T cell pools was examined
at 20 dpi. As expected, no CD45.2+ KO or CD45.1+ WT
CD8+ T cells were detected in infected F1 (CD45.1+/CD45.2+)
WT hosts that were not injected (control mice). When
analyzing the competitive adoptive transfer experiment, we
observed that within the population of injected cells, IL-
17RA KO CD8+ T cells were outcompeted by their WT
counterparts in both total and parasite-specific CD8+ T cell
subsets in all the organs examined, including blood and spleen
(Figure 6E).
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FIGURE 6 | Intrinsic IL-17RA-signaling modulates the maintenance, phenotype and function of CD8+ T cells during T. cruzi infection. (A) Concentration of IL-21 in
plasma of infected (20 dpi) WT and IL-17RA KO mice. Data are presented as mean ± SD, N = 4 mice. (B) Amounts of Il17ra, Il17rc, and Il17rd transcript determined
in CD8+ T cells purified from the spleen of non-infected WT mice, normalized to 18S RNA. Data are presented as mean ± SD, N = 4 mice (C) Representative
histograms of the expression of IL-17RA (protein) on total, memory and effector CD8+ T cell subsets defined according to CD44 and CD62L staining in spleen cell
suspensions from non-infected (N) and infected (I) WT mice (14 dpi). Staining of IL-17RA on spleen CD8+ T cells from IL-17RA KO mice is showed as negative
control. (D) Kinetic evaluation of the upregulation of IL-17RA (MFI: mean of fluorescence intensity) induced by T. cruzi expression on bulk effector and memory CD8+
T cells and TSKB20-specific CD8+ T cells. Data in statistical analysis are presented as mean ± SD, N = 4. (E) Representative plots and statistical analysis of CD8
and TSKB20/Kb staining and of CD45.1 and CD45.2 staining within Total and TSKB20/Kb+ CD8+ T cells in the blood and spleen of infected CD45.1/CD45.2 WT
(Continued)
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FIGURE 6 | recipient mice (20 dpi) non-injected (control) or injected with equal numbers of CD45.1+ WT and CD45.2+ KO CD8+ T cells. Numbers in the plots
indicate the frequency of the correspondent cell subset. Bar graphs display the frequency of CD45.1+ WT cells and CD45.2+ KO cells within the indicated
populations upon gating only in the injected cells. (F) Representative plots and statistical analysis of CD8 and TSKB20/Kb staining and of CD45.1 and CD45.2 staining
within Total and TSKB20/Kb+ CD8+ T cells in the spleen of infected CD8α-/- recipients (17 dpi) injected with equal numbers of CD45.1+ WT and CD45.2+ KO
CD8+ T cells. Pie charts display the frequency of CD45.1+ WT and CD45.2+ KO cells within the indicated gates. Bar graph shows the ratio between the frequencies
of TSKB20/Kb+ CD8+ T cells and the total CD8+ T cells within CD45.1 WT and CD45.2 IL-17RA KO populations. (G) Representative histograms and statistical
analysis of the geometric mean of PD-1 expression in total and TSKB20/Kb+ CD8+ T cells within CD45.1+ WT and CD45.2+ IL-17RA KO CD8+ T cells from the
spleen of CD8α-/- recipient mice. Data in statistical analysis are presented as mean ± SD, N = 4−6 mice. (H) Percentage of polyfunctional effector cells denoted by
expression CD107a, IFNγ and/or TNF upon 5 h of the indicated stimulation on CD45.1+ WT and CD45.2+ IL-17RA KO CD8+ T cells from the spleen of CD8α-/-
recipient mice. Data shown as mean ± SD, N = 4 mice. Data were background subtracted. All P values in (E–G) were calculated using two-tailed T test. Data are
representative of two independent experiments. (I) Experimental layout of the adoptive transfer of equal number of CD8+ T cells purified from WT mice or IL-17RA KO
mice into CD8α knockout mice immediately followed by T. cruzi infection. N = 3 mice/group. (J) Representative dot plots of the frequency of CD8+ T cells determined
1 day after injection in blood of the different experimental groups. (K) Parasitemia (15 dpi) in the different experimental groups. Infected non-transferred CD8α
knockout mice were used as control. P value calculated using Gehan-Breslow-Wilcoxon Test. Data in (A–J) are representative of two independent experiments.
To overcome the possible limitations derived from the
presence of endogenous WT CD8+ T cells in lymphoreplete
hosts, we repeated the competitive adoptive transfer experiment
in CD8α-/- mice. At 17 dpi, the frequency of IL-17RA
KO cells was double that of WT cells within the total
population of CD8+ T cells (Figure 6F), likely as result
of increased homeostatic proliferation of polyclonal IL-
17RA KO CD8+ T cells (Figure 2A). In contrast, WT cells
significantly outnumbered IL-17RA KO cells within the
TSKB20-specific CD8+ T cell pool, indicating that intrinsic
expression of IL-17RA provides a maintenance advantage
for parasite-specific CD8+ T cells. Indeed, the ratio between
the percentage of WT CD8+ T cells within TSKB20-specific
gate and the polyclonal total CD8+ T cells was significantly
higher than that of IL-17RA KO CD8+ T cells (Figure 6F).
Phenotypic evaluation revealed that IL-17RA KO CD8+ T
cells exhibited higher expression of the inhibitory receptor
PD-1 (Figure 6G). Upon antigen specific stimulation with
TSKB20, WT CD8+ T cells exhibited a significantly higher
polyfunctional effector response in comparison to IL-17RA KO
CD8+ T cell from the same host (Figure 6H, left panel and
Supplementary Figure 5). An identical result was observed
after polyclonal stimulation (Figure 6H, right panel and
Supplementary Figure 5).
Finally, we aimed to address the relevance of CD8+ T
cell-intrinsic IL-17RA signaling for host protection during
T. cruzi infection. To this end, we evaluated the ability to
control parasite replication in CD8α-/- mice transferred with
IL-17RA KO CD8+ T cells in comparison to CD8α-/- mice
transferred with WT CD8+ T cells (Figure 6I). As a control,
we determined that the frequency of circulating CD8+ T
cells at day one post-injection was the same between both
groups of mice (Figure 6J). CD8α-/- mice were extremely
susceptible to T. cruzi infection and displayed uncontrolled
parasitemia at day 21, even with an infection dose of 100
trypomastigotes, which was 50 times less than the dose used in
previous experiments. Furthermore, all these mice succumbed
by day 25 post-infection (data not shown). Remarkably,
the transfer of IL-17RA-sufficient WT CD8+ T cells, but
not of IL-17RA-deficient KO CD8+ T cells, was able to
enhance parasite control and significantly reduce parasitemia
(Figure 6K).
DISCUSSION
During the last few decades, many reports have delineated the
immunological mechanisms underlying IL-17-mediated roles in
host protection against infection as well as in inflammatory
diseases (39, 40). In this study, we uncover a novel mechanism
by which IL-17RA signaling regulates CD8+ T cell responses and
promotes protection against a protozoan infection. Our findings
provide new elements to elucidate the cytokines and pathways
leading to robust CD8+ T cell responses against infections with
intracellular microbes and consequently, may have important
implications for vaccine and therapy design.
The integral role of the IL-17 family in host defense against
extracellular bacterial and fungal pathogens has been well
established, and recent studies have implicated the family of
genes in potentiating immunity against intracellular bacteria,
viruses, and parasites (3). So far, the IL-17-dependent protective
mechanisms were believed to be dependent on the activation
of both non-immune and innate immune cells to sustain
inflammation (8). Notably, the IL-17 family of proteins only
indirectly promotes adaptive cellular immune responses (41, 42).
In this regard, there is evidence to suggest the role of IL-17
cytokines in sustaining specific CD8+ T cell responses that
promote host resistance to Listeria infection and melanoma
(43, 44). In these settings, the IL-17-mediated induction of
protective CD8+ T cells depended on enhanced recruitment
of cross-presenting dendritic cells, although direct effects on
CD8+ T cells were not ruled out. Very recently, IL-17 was
shown to directly potentiate CD8+ T cell cytotoxicity against
West Nile Virus infection (9). In line with this, we demonstrate
that mice deficient in IL-17RA showed an abortive CD8+ T
cell response during T. cruzi infection characterized by an
early reduction in the number of parasite-specific CD8+ T
cells. Concomitantly, infected IL-17RA KO mice showed poor
control of the parasite in target tissues such as spleen, liver,
and heart. By using different experimental approaches, including
detailed phenotypic, functional and transcriptional profiling
of CD8+ T cells from IL-17RA KO mice infected with T.
cruzi, we demonstrated that CD8+ T cell-intrinsic IL-17RA
signaling is required to sustain CD8+ T cell maintenance and
pathogen-specific CD8+ T cell immunity, particularly during the
expansion phase.
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Whether one or more of the four cytokines that signal through
IL-17RA is involved in these events is currently unknown.
However, our results led us to postulate that IL-17A is the main
cytokine involved in the IL-17RA-mediated effect of CD8+ T
cells. This postulate is based on the marked similarities in the
phenotype of the infected IL-17A/F DKO and IL-17RA KO mice
and the significant consequences of the IL-17A neutralization in
mice and IL-17A supplementation in CD8+ T cell cultures. Still,
a possible role of other members of this family are not ruled
out given that at least two other the IL-17RA signaling cytokines
besides IL-17A (i.e., IL-17F and IL-17E/IL-25) are increased
during T. cruzi infection (4). Regarding receptor expression, we
determined that CD8+ T cells express the transcripts encoding
not only IL-17RA but also IL-17RC and IL-17RD. Of note, we
determined that Il17ra transcripts are present in significantly
higher amounts than Il17rc and Il17rd. These findings are
noteworthy as high levels of IL-17RA seem to be required
for effective responses to IL-17 (45), and also because they
also pose the question of whether IL-17RC or IL-17RD are
effectively expressed on CD8+ T cells and required for IL-17
signal transduction. Although, the receptor complex formed by
IL-17RA and IL-17RC is considered essential for IL-17 signal
transduction (46), some studies reported that hematopoietic cell
types (including T cells) show IL-17-dependent responses even in
the absence of IL-17RC (47–49). It should be further established
whether IL-17RD may interact with IL-17RA and replace IL-
17RC to mediate the IL-17 signaling in these populations as
previously reported (37). In the same direction, to dissect the
precise signaling requirement for IL-17 signal transduction in
CD8+ T cells may provide important information in terms of
the IL-17 biology.
Besides a direct role of IL-17 cytokines, it is possible that
a crosstalk of IL-17 with other cytokines that regulate CD8+
T cell fate such as IL-21 might be indirectly involved in the
observed qualitative defects. In this regard, Hoft and colleagues
described that TCR-transgenic CD4+ T cells specific for an
immunodominant peptide of T. cruzi that were polarized in vitro
into Th17 cells could potentiate CD8+T cell immunity through a
mechanism that is IL-21-dependent, but IL-17-independent (50).
It remains to be established whether the in vitro generated Th17
cells are equivalent to those differentiated in vivo within the host
during T. cruzi infection. Indeed, we determined that infected
IL-17RA KO mice displayed higher concentrations of serum IL-
21 than infected WT control mice, suggesting that the altered
CD8+ T cell response observed in absence of IL-17RA signaling
is unlikely to be a result of deficient IL-21 production.
CD8+ T cells from infected IL-17RA KO mice showed
increased apoptosis and a transcriptional landscape associated
with canonical cell death and senescence pathways. In addition,
these cells exhibited high expression of multiple inhibitory and
death receptors that correlated with reduced ex vivo effector
responses and a gene signature that positively correlated with
those defined for dysfunctional PD-1high CD8+ T cells (51,
52). Altogether, these features partially resembled those of
dysfunctional CD8+ T cells described inmany chronic infections
and cancer that are characterized by the progressive loss of T cell
function, sustained expression of inhibitory receptors, and high
susceptibility to deletion (53). Interestingly, we found that the
functional CD8+ T cell response observed in T. cruzi-infected
WT mice [this manuscript and (54)] was significantly impaired
in the absence of IL-17RA signaling. In this regard, although it
is conceivable that the increased tissue parasitism in IL-17RA
KO mice favored CD8+ T cell exhaustion, infection of WT
mice with increasing parasite loads does not induce expression
of inhibitory receptors or deletion of parasite-specific CD8+ T
cells, nor does it result in impaired CD8+ T cell cytotoxic effector
function (55). As cytokines are essential for the regulation of
exhaustion (20), we performed adoptive transfer experiments
that supported the notion that IL-17 signaling influenced CD8+
T cell survival and function partially through cell intrinsic
mechanisms. Interestingly, we determined that IL-17RA is
expressed at different levels according to each particular CD8+
T cell subset. Specifically, IL-17RA expression was increased
and sustained in memory cells, but was transiently up-regulated
in activated effector cells at early stages of infection. These
results, together with those showing that IL17RA downregulation
is included in the gene signature of exhausted T cells (56,
57), suggest that the IL-17/IL-17RA pathway modulates CD8+
T cell fate, thus preventing cell exhaustion in activated cells
and sustaining long-lasting cytotoxic responses. In this regard,
adoptive transfer of WT, but not of IL-17RA KO CD8+ T cells,
promoted parasite control in immuno-deficient CD8α-/- mice.
In line with this, we demonstrated that anti-PD-L1 Abs during
the CD8+ T cell expansion phase reinvigorated the parasite-
specific CD8+ T cell responses in infected IL-17RA KO mice,
thus restoring robust parasite control and reducing pathology
to levels comparable to infected WT controls. Remarkably, we
observed that a short regimen of PD-L1 neutralization increased
the frequency of parasite-specific CD8+ T cells by two-fold in
both treated groups, although the magnitude of the response in
infected IL-17RA KO mice remained lower than in WT control
mice. Given the high levels of inhibitory receptors in CD8+ T
cells elicited by T. cruzi infection in absence of IL-17RA, it is
likely that the combination of different checkpoint Abs may have
a stronger effect in these settings, as reported in cancer models
(58).
The role of checkpoint inhibitors during T. cruzi infection,
particularly the PD-1/PD-L1 axis, has been understudied thus
far. One report demonstrated that genetic disruption of this
inhibitory pathway increased the effector immune response to
favor parasite control, but also promoted cardiac pathology
and compromised host resistance to the infection (59). In this
context, our data provide evidence that a PD-L1 checkpoint
blockade at the CD8+ T cell expansion phase not only restored
resistance to T. cruzi absence of IL-17RA signaling, but also
boosted protective CD8+ T cell immunity during the natural
infection. These findings are relevant to a growing area of
research aimed at investigating the therapeutic potential of
immune checkpoint pathways during chronic infections (60).
In recent years, several reports have shown that immune cell
exhaustion or dysfunction is a common finding in human
Chagas disease, particularly in patients with severe symptoms
(61–64). There is certain consensus that even very low parasite
loads in tissues may drive, in the long term of the human
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infection (two decades), the expression of inhibitory receptors
and cell dysfunction in T cells. Consequently, this likely drives
an immune modulatory mechanism and reduced tissue damage
in the later stages of infection. Interestingly, many reports
have described that patients with moderate to severe chronic
chagasic cardiomyopathy have reduced production of IL-17,
supporting a protective role of the cytokine against cardiac
damage (65, 66). Altogether, previous findings and those reported
here support the hypothesis that elevated IL-17 production in
the context of persistent parasite levels may prevent T cell
dysfunction and the associated immune imbalance that cause
chronic myocarditis. Given the relevance for the understanding
of the immunopathology during human Chagas disease, this
hypothesis merits further investigation in future studies.
The comparison of the transcriptome of CD8+ T cells from
infected IL-17RA KO and WT mice supported the notion
that IL-17RA signaling influences the transcriptional program
of effector CD8+ T cells. These conclusions were based on
the transcriptome of bulk CD8+ T cells and, consequently,
may present some caveats as result of the heterogeneity of
the sample and the “dilution” of the parasite-specific response.
However, we determined that during T. cruzi infection most
CD8+ T cells acquire an activated phenotype. Furthermore,
total and TSKB20-specific CD8+ T cells from infected WT
and IL-17RA KO mice exhibit similar expression of activation
and differentiation markers and inhibitory and death receptors.
Moreover, despite the fact that TSKB20-specific CD8+ T cells
were the immunodominant population within effector cells,
CD8+ T cells specific for other parasite peptides (i.e., TSKB18)
were also detectable in infected WT and IL-17RA KO mice
(data not shown). Accordingly, we consider that transcriptomic
profiling of bulk CD8+ T cells activated during T. cruzi
infection, though with some limitations, provides meaningful
evidences about the role of IL-17RA signaling in dictating the
transcriptional program of effector CD8+ T cells. Interestingly,
the IPA analysis of the transcriptome of CD8+ T cells arising
IL-17RA KO mice infected with T. cruzi highlighted IRF4 and,
to a minor extent, BATF as potential upstream regulators of
the IL-17RA phenotype. Notably, both TFs have been reported
to be required for survival and differentiation of early effector
CD8+ T cells (67–72). IRF4 promotes CD8+ T cell expansion
and differentiation (69), but it also induces the expression of
molecules associated with an exhausted status such as Blimp-
1, CTLA-4, and IL-10 (73–75). Furthermore, BATF expression
may be triggered by PD-1 ligation and associated with CD8+
T cell exhaustion during chronic viral infection in humans and
mice (76). Very recently, IRF4 and BATF have been shown to
form a TCR-responsive transcriptional circuit that establishes
and sustains T cell exhaustion during chronic viral infection
(77). Therefore, it is conceivable that sustained elevated levels
of both TFs could result in the induction of cell death and
exhaustion program observed in CD8+ T cells from infected IL-
17RA KO mice. The link between IL-17RA signaling, expression
of BATF and IRF-4, and CD8+ T cell exhaustion deserves further
investigation using genetic dissection approaches.
In conclusion, our results provide evidence for a novel
IL-17RA-mediated mechanism that potentiates immunity to
intracellular pathogens such as T. cruzi by improving adaptive
CD8+ T cell responses. These findings, taken together with the
report showing that IL-17 controls functional competence of NK
cells during a fungal infection (78), suggest that the IL-17 family
is likely important for both the innate and adaptive arms of the
cytotoxic response against pathogens. Although it remains to
be determined whether this mechanism can be applied to host
resistance mediated by IL-17 cytokines in the context of other
infections, these findings have two fundamental repercussions
in the field of IL-17-mediated immune responses. The first is
that the prolonged targeting of the IL-17 pathways as part of
an anti-inflammatory treatment during autoimmune diseases or
cancer may potentially have harmful effects due to defective
cytotoxic responses. The second is the notion that promoting the
production of IL-17 cytokines during infection or vaccination
may help to elicit stronger cytotoxic responses to fight against
microbes, and eventually, tumors.
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Supplementary Figure 1 | Complementary evaluation of parasite-specific CD8+
T cell responses and tissue parasitism in T. cruzi-infected IL-17A/IL-17F DKO
mice. (A) Relative amount of T. cruzi satellite DNA in spleen and liver of infected
WT and IL-17A/IL-17F DKO mice determined at 22 dpi. Murine GAPDH was used
for normalization. (B) Representative plots and statistical analysis of CD8 and
TSKB20/Kb staining in spleen of WT and IL-17A/IL-17F DKO mice at 22 dpi.
Numbers on plots represent the frequency of TSKB20/Kb+ CD8+ T cells. (C–D)
Representative histograms and statistical analysis of the geometric mean
expression of the inhibitory receptor PD-1 (C) and the death receptor CD95/Fas
(D) in total and TSKB20/Kb+ spleen CD8+ T cells from WT and IL-17A/IL-17F
DKO mice at 22 dpi. Gray tinted histogram show staining in CD8+ T cells from
non-infected WT mice. Data in statistical analysis (A–D) are presented as mean ±
SD, N = 4−6 mice. P values calculated with two-tailed T test. (A–D) Data are
representative of at least three independent experiments.
Supplementary Figure 2 | Complementary studies of proliferation and apoptosis
in total and parasite-specific CD8+ T cells in WT and IL-17RA KO infected mice.
(A,B) Representative histograms and statistical analysis of Ki-67 (A) and Annexin
V (B) staining within the 7ADD- gate in total (left) and TSKB20/Kb+ (right) CD8+ T
cells from the spleen of WT and IL17RA KO mice at 10 dpi (B) and/or 20 dpi
(A,B). Gray tinted histogram show staining in CD8+ T cells from non-infected (N)
WT mice. Histograms are representative of one out of five mice. Numbers indicate
the frequency of Ki-67+ (A) and Annexin V+ (B) cells from the corresponding
colored group. Bar graphs represent data as mean ± SD, N = 4 mice. P values
calculated with two-tailed T test. (C) Representative histograms of TMRE staining
in total (left) and TSKB20/Kb+ (right) CD8+ T cells from the spleen of infected WT
mice treated with isotype control or anti-IL-17 as described in Figure 1G. Gray
tinted histogram show staining in CD8+ T cells from non-infected WT mice.
Numbers indicate the frequency of TMRElow (apoptotic) cells from the
corresponding colored group. Histograms are representative of one out of seven
mice. Bar graphs in the statistical analysis represent data as mean ± SD, N = 7
mice. P values calculated with two-tailed T test. (D) Representative plots (N = 3)
of TMRE and LIVE/DEAD fixable aqua staining showing the frequency of cells in
early apoptosis (TMRE LIVE/DEAD) and in late apoptosis/necrosis (TMRE
LIVE/DEAD+ ) within cell cultures of CD8+ T cells purified from non-infected WT
and IL-17RA KO mice and activated during 24 h with coated anti-CD3 and
anti-CD28 in the presence of the indicated combinations of medium, IL-17A
(100 ng/mL) and camptothecin (CPT, 5µM). (E) Representative histograms of the
expression of Bcl-2, Bim and Bax in cultures of purified CD8+ T cells activated
during 24 h with coated anti-CD3 and anti-CD28 in the presence of medium or
IL-17A (100 ng/mL) as indicated. (A–E) Data are representative of two
independent experiments.
Supplementary Figure 3 | Representative flow cytometry data plots of the
evaluation of CD8+ T cell effector function. (A) Representative plots of the
expression of Granzyme A (GzmA), Perforin (Prf) and Granzyme B (GrmB)
determined after 5 h of PMA/ionomicin stimulation in spleen cells from
non-infected (gray dots) and 22-day infected (blue dots) WT mice and in
non-infected (black dots) and 22-day infected (red dots) IL-17RA KO mice. Plots
are gated within CD8+ T cells. Numbers indicate the frequency of cells expressing
the corresponding effector molecule within the infected groups. Data
representative of two independent experiments with N = 3/group. (B)
Representative plots and analysis strategy of the frequency of spleen CD8+ T
cells from infected WT and IL-17RA KO mice (22dpi) showing a combination of
three and two effector function including expression of CD107a, IFNγ and/or TNF
upon 5 h of culture with the indicated stimulation. Plots are representative of one
out of five mice. Data are representative of two independent experiments.
Supplementary Figure 4 | Increasing parasite doses did not diminish the
frequency of parasite-specific CD8+ T cells cells or upregulated inhibitory
receptors on CD8+ T cells. (A) Parasitemia at 22 dpi determined in the blood of
WT mice infected with increasing doses of parasites (500, 5,000 and 50,000
tripomastigotes). (B) Representative plots and statistical analysis of CD8 and
TSKB20/Kb staining in spleen of WT infected as described in (A). (C,D) Statistical
analysis of the geometric mean of expression of inhibitory (C) and death (D)
receptors in total and TSKB20/Kb+ CD8+ T cells from WT mice infected as
described in A. Data in statistical analysis are presented as mean ± SD, N = 4−6
mice. P values calculated with two-tailed T test. (A–D) Data are representative of
at least 2 independent experiments.
Supplementary Figure 5 | Representative flow cytometry data plots of the
evaluation of CD8+ T cell effector function in mice adoptively transferred.
Representative plots and analysis strategy of the frequency of CD45.1+ WT and
CD45.2+ IL-17RA KO CD8+ T cells from the spleen of CD8α-/- mice adoptively
transferred and infected as indicated for Figure 6E. The plots show a
combination of three and two effector function including expression of CD107a,
IFNγ, and/or TNF upon 5 h of culture with the indicated stimulation. Plots are
representative of one out of four mice. Data are representative of two independent
experiments.
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